[225Ac]AcFAPI-46

N/A

Report date: 2025/11/20 16:04:33

Base Information

Drug Name[225Ac]AcFAPI-46

Drug Alias Name[225Ac]FAPI-46

ClassificationRadiation-emitting products > Nuclides > Actinium > 225AcRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Radioactive diagnostic agent +[4]

Mechanisms of ActionFibroblast activation protein alpha inhibitorsPositron-emission tomography enhancers

TargetsProlyl endopeptidase FAP

Therapy Area/IndicationsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesOsaka University

China Registration ClassN/A

Develop Information

Active CompaniesOsaka University

Inactive CompaniesN/A

Active IndicationsPancreatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A